维普期刊资源整合服务平台（V6.5）

66篇 您的检索式：作者名="MAHLKNECHT U"

选中清除导出查看参考文献查看引证文献引用追踪共4页首页上一页第1页下一页末页 /4 跳转

	题名	作者	年代	出处	被引量
1	Azacytidine causes complex DNA methylation responses in myeloid leukemia显示文摘	Stresemann C Bokelmann I Mahlknecht U	2008	Mol Cancer Ther2008，7，9：	1
2	Valproic acid and all-trans retinoic acid: meta-analysis of a palliative treatment regimen in AML and MDS patients显示文摘	Bellos F Mahlknecht U	2008	Onkologie2008，31，11：	1
3	The histone deacetylase inhibitor suberoylanilide hydroxamic acid down-regulates expression levels of Bcr-abl,c-Myc and HD AC3 in chronic myeloid leukemia cell lines显示文摘	Xu Y Voelter-Mahlknecht S Mahlknecht U	2005	Int J Mol Med2005，15，1：	1
4	SIRTUIN 1: regulating the regulator显示文摘	Zschoernig B Mahlknecht U	2008	Biochem Biophys Res Commun2008，376，2：	1
5	Role of histone deacetylase inhibitors in the treatment of cancer显示文摘	Mei S Ho A D Mahlknecht U	2004	Int J Oncol2004，25，6：	1
6	The histone deacetylase inhibitor suberoylanilide hydroxamic acid down-regulates expression levels of Bcr-abl,c-Myc and HDAC3 in chronic myeloid leukemia cell lines显示文摘	Xu Y Voelter-Mahlknecht S Mahlknecht U	2005	Int J Mol Med2005，15，1：	1
7	Histone deacetylase inhibitor treat-ment downregulates VLA-4 adhesion in hematopoietic stem cellsand acute myeloid leukemia blast cells显示文摘	Mahlknecht U Schonbein C	2008	Haematologica2008，93，3：	1
8	Valproic acid sensitizes chronic lymphocytic leukemia cells to apoptosis and restores the balance between pro-and antiapoptotic proteins显示文摘	Bokelmann I Mahlknecht U	2008	Mol Med2008，14，12：	1
9	The histone deace-tylase inhibitor suberoylanilide hydroxamic acid down-regulates expression levels of Bcr-abl,c-Myc and HDAC3 in chronic myeloid leukemia cell lines显示文摘	Xu Y Voelter-Mahlknecht S Mahlknecht U	2005	Int J Mol Med2005，15，1：	1
10	Valproic acid and all-trans retinoic acid:meta-analysis of palliative treatment regimen in AML and MDS patients显示文摘	Bellos F Mahlknecht U	2008	Onkologie2008，31，：	1
11	Cloning,chromosomal char-acterization and mapping of the NAD-dependent histone deacety-lases gene sirtuin 1 显示文摘	Voelter-Mahlknecht S Mahlknecht U	2006	Int J Mol Med2006，17，1：	1
12	Histone acetylation modifiers in the pathogensis of malignant disease显示文摘	Mahlknecht U Hoelzer D		0，，08：	1
13	Valproic acid and all-trans retinoic acid:meta-analysis of a palliative treatment regimen in AML and MDS patients显示文摘	Bellos F Mahlknecht U	2008	Onkologie2008，31，11：	1
14	Stem cells and ageing The potential of stem cells to overcome age-related deteriorations of the body in regenerative medicine显示文摘	Ho AD Wagner W Mahlknecht U		0，，：	1
15	Chromosomal organization and localization of the novel class IV human histone deacetylase 11 gene 显示文摘	Voelter-Mahlknecht S Ho AD Mahlknecht U	2005	Int J Mol Med2005，16，：	1
16	Azacytidine causes complex DNA methylation responses in myeloid leukemia 显示文摘	Stresemann C Bokelmann I Mahlknecht U	2008	Molecular Cancer Terapeutics2008，7，9：	1
17	The histone deacetylase inhibitor suheroylanilide hydroxamie acid down regulates expression levels of bcr-abl c-myc and HDAC3 in chronic myeloid leukemia cell lines显示文摘	Xu Y Voelter-Mahlkneeht S Mahlknecht U	2005	Int J Mol Med2005，15，1：	1
18	Histone acetylation modifiers in the pathogensis of malgnant disease 显示文摘	MAHLKNECHT U HOELZER D	2000	Mol Med2000，6，8：	1
19	Cloning and characterization of the murine histone deacetylase(HDAC3)显示文摘	Mahlknecht U Hoelzer D Bucala R	1999	Biochem Biophys Res Commun1999，263，2：	1
20	Histone acetylation modifiers in the pathogenesis of malignant disease显示文摘	Mahlknecht U Hoelzer D	2000	Mol Med2000，6，8：	1

返回顶部每页显示：

共4页首页上一页第1页下一页末页 /4 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示